Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

Bruker Corporation designs, manufactures, and markets proprietary life science systems based on spectrometry technology platforms. The Company also sells a range of field analytical systems for substance detection and pathogen identification. Bruker develops life science and advanced materials research tools based on X-ray technology.
Website: bruker.com



Growth: Bad revenue growth rate -0.3%, there is slowdown compared to average historical growth rates 11.3%. The revenue growth dynamics is moderately stable Site traffic for the last 3 months showed a change of -0.8%

Profitability: LTM EBITDA margin is positive, +8.1%. On average the margin is decreasing unsteadily. Gross margin is high, +44.9%. In the last quarter the company beat the estimated EPS, +16.4%. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.06 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.4%. Free cash flow yield 6.1% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 65.0% higher than minimum and 48.6% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.3x by EV / Sales multiple , the company can be 12.3% overvalued

Insiders: For the last 3 months insiders sold company shares on $2.4 mln (-0.032% of cap.)

Key Financials (Download financials)

Ticker: BRKR
Share price, USD:  (0.0%)48.44
year average price 41.12  


year start price 51.13 2025-02-10

max close price 53.50 2025-02-20

min close price 29.35 2025-09-03

current price 48.44 2026-02-09
Common stocks: 149 255 013

Dividend Yield:  0.4%
FCF Yield LTM: 6.1%
EV / LTM EBITDA: 32.2x
EV / EBITDA annualized: 561.7x
Last revenue growth (y/y):  -0.3%
Last growth of EBITDA (y/y):  -96.6%
Historical revenue growth:  +11.3%
Historical growth of EBITDA:  -15.1%
EV / Sales: 2.6x
Margin (EBITDA LTM / Revenue): 8.1%
Fundamental value created in LTM:
Market Cap ($m): 7 230
Net Debt ($m): 1 758
EV (Enterprise Value): 8 988
Price to Book: 3.0x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-01-23seekingalpha.com

Artisan Small Cap Fund Q4 2025 Portfolio Activity

2025-12-26zacks.com

Should You Continue to Hold BRKR Stock in Your Portfolio?

2025-06-30zacks.com

BRKR Stock Gains Following the Multi-System Advanced Packaging Order

2025-04-23globenewswire.com

Solis Agrosciences Names Crystal Winkeler Chief Business Officer to Drive Commercial Growth

2025-01-14zacks.com

BRKR Stock Up on the Launch of LUMOS II ILIM QCL-Based IR Microscope

2024-11-12zacks.com

New Strong Sell Stocks for November 12th

2024-11-11zacks.com

BRKR Stock Declines Despite Launching EpicIF Technology for CellScape

2024-11-07zacks.com

BRKR Misses on Q3 Earnings, Cuts '24 View, Stock Up in Aftermarket

2024-10-17globenewswire.com

Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress

2024-10-09zacks.com

BRKR Stock Might Gain From the Newly Launched OptoVolt Module
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-05 2025-08-06 2024-11-05 2024-08-09 2024-05-10 2023-11-09 2023-08-09 2023-05-10 2022-11-04
acceptedDate 2025-11-05 16:30:06 2025-08-05 19:05:54 2025-03-03 16:27:32 2024-11-05 07:00:10 2024-08-09 16:41:48 2024-05-10 15:29:53 2024-02-29 15:58:08 2023-11-09 16:54:36 2023-08-09 15:27:25 2023-05-10 15:10:36 2022-12-31 00:00:00 2022-11-04 15:11:06 2022-02-28 10:46:59 2021-03-01 15:37:40
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 861M 797M 3 366M 864M 801M 722M 2 965M 743M 682M 685M 2 531M 639M 2 418M 1 988M
costOfRevenue 474M 440M 1 717M 454M 411M 365M 1 451M 360M 341M 326M 1 225M 304M 1 208M 1 048M
grossProfit 386M 358M 1 650M 410M 390M 357M 1 513M 383M 341M 360M 1 306M 335M 1 210M 940M
grossProfitRatio 0.449 0.449 0.475 0.486 0.494 0.515 0.499 0.525 0.525
researchAndDevelopmentExpenses 98M 100M 377M 98M 92M 82M 295M 71M 71M 69M 236M 56M 221M 198M
generalAndAdministrativeExpenses 0 0 894M 239M 221M 195M 730M 178M 178M 163M 610M 145M 562M 478M
sellingAndMarketingExpenses 0 0 0 -9M 300 000 300 000 -600 000 0 0 0 -2M 0 0 0
sellingGeneralAndAdministrativeExpenses 227M 231M 894M 230M 221M 195M 729M 178M 178M 163M 607M 145M 562M 478M
otherExpenses -6M 14M 126M 14M -2M -800 000 52M -9M -5M -5M 30M 0 13M 16M
operatingExpenses 319M 346M 1 396M 351M 315M 278M 1 076M 249M 249M 232M 873M 201M 796M 692M
costAndExpenses 794M 786M 3 113M 796M 727M 650M 2 528M 609M 590M 557M 2 098M 505M 2 005M 1 739M
interestIncome 0 3M 9M 2M 2M 3M 8M 2M 2M 1M 3M 0 900 000 3M
interestExpense 20M 16M 48M 12M 16M 7M 16M -5M -9M -16M 16M -2M 14M 14M
depreciationAndAmortization 56M 56M 184M 51M 45M 35M 115M 27M 26M 30M 89M 24M 89M 80M
ebitda 3M 72M 439M 119M 126M 113M 676M 161M 118M 153M 519M 155M 497M 321M
ebitdaratio 0.004 0.091 0.138 0.149 0.157 0.216 0.172 0.223 0.243
operatingIncome 67M 12M 253M 68M 74M 79M 437M 125M 86M 123M 433M 131M 413M 248M
operatingIncomeRatio 0.078 0.015 0.079 0.093 0.109 0.168 0.126 0.179 0.206
totalOtherIncomeExpensesNet -140M -11M -48M -13M -24M -7M 109M -9M -5M -16M -18M -2M -20M -23M
incomeBeforeTax -73M 1M 205M 55M 24M 72M 546M 119M 78M 107M 415M 129M 394M 226M
incomeBeforeTaxRatio -0.084 0.001 0.064 0.03 0.099 0.16 0.114 0.156 0.202
incomeTaxExpense -14M -3M 91M 15M 16M 20M 118M 31M 20M 30M 116M 41M 113M 64M
netIncome -60M 8M 113M 41M 8M 51M 427M 88M 57M 77M 297M 88M 277M 158M
netIncomeRatio -0.069 0.01 0.047 0.009 0.071 0.119 0.084 0.112 0.138
eps -0.411 0.05 0.76 0.28 0.052 0.35 2.92 0.6 0.39 0.52 2 0.6 1.83 1.03
epsdiluted -0.411 0.05 0.28 0.051 0.35 0.6 0.39 0.52 0.59
weightedAverageShsOut 152M 152M 149M 148M 147M 145M 146M 147M 147M 147M 149M 148M 151M 153M
weightedAverageShsOutDil 152M 152M 150M 149M 148M 146M 147M 147M 148M 148M 149M 149M 153M 155M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-03 2024-02-29 2022-12-31 2022-02-28 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome -39M -9M -13M -13M -11M
ebit 255M 561M 430M 408M 240M
nonOperatingIncomeExcludingInterest -2M -124M 3M 5M 8M
netIncomeFromContinuingOperations 114M 429M 299M 281M 161M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 113M 427M 297M 277M 158M
epsDiluted 0.76 2.9 1.99 1.81 1.02

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-05 2025-08-06 2024-11-05 2024-08-09 2024-05-10 2023-11-09 2023-08-09 2023-05-10 2022-11-04
acceptedDate 2025-11-05 16:30:06 2025-08-05 19:05:54 2025-03-03 16:27:32 2024-11-05 07:00:10 2024-08-09 16:41:48 2024-05-10 15:29:53 2024-02-29 15:58:08 2023-11-09 16:54:36 2023-08-09 15:27:25 2023-05-10 15:10:36 2022-12-31 00:00:00 2022-11-04 15:11:06 2022-02-28 10:46:59 2021-03-01 15:37:40
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 295M 92M 183M 148M 170M 340M 488M 364M 575M 598M 646M 626M 1 068M 682M
shortTermInvestments 0 0 0 0 13M 13M 0 19M 0 0 0 0 100M 50M
cashAndShortTermInvestments 295M 92M 183M 148M 170M 340M 488M 364M 575M 598M 646M 626M 1 168M 732M
netReceivables 673M 739M 701M 538M 694M 636M 622M 485M 451M 472M 595M 421M 417M 335M
inventory 1 197M 1 218M 1 068M 1 220M 1 176M 1 061M 968M 916M 915M 859M 800M 750M 710M 692M
otherCurrentAssets 186M 114M 40M 285M 113M 104M 30M 264M 243M 208M 29M 240M 177M 166M
totalCurrentAssets 2 351M 2 163M 2 053M 2 191M 2 153M 2 140M 2 164M 2 029M 2 183M 2 136M 2 113M 2 037M 2 472M 1 925M
propertyPlantEquipmentNet 747M 759M 815M 694M 793M 691M 691M 527M 523M 511M 538M 422M 466M 463M
goodwill 1 550M 1 649M 1 507M 1 475M 1 444M 752M 583M 561M 558M 527M 458M 382M 340M 320M
intangibleAssets 919M 970M 913M 1 027M 1 024M 449M 331M 292M 300M 299M 271M 214M 212M 229M
goodwillAndIntangibleAssets 2 469M 2 619M 2 420M 2 501M 2 468M 1 201M 913M 1 262M 1 151M 1 117M 729M 879M 551M 550M
longTermInvestments 8M 0 0 0 11M 22M 0 19M 0 0 0 0 0 0
taxAssets 0 0 286M 0 303M 280M 297M -410M 0 0 77M 0 90M 72M
otherNonCurrentAssets 861M 800M 233M 727M 174M 172M 184M 391M 0 0 155M 0 71M 40M
totalNonCurrentAssets 4 084M 4 177M 3 754M 3 922M 3 750M 2 366M 2 086M 1 789M 1 674M 1 628M 1 499M 1 300M 1 178M 1 124M
otherAssets 0 0 0 0 0 1 0 0 0 0 0 0 0 0
totalAssets 6 435M 6 340M 5 807M 6 113M 5 903M 4 506M 4 250M 3 818M 3 857M 3 764M 3 612M 3 337M 3 650M 3 049M
accountPayables 184M 243M 234M 228M 220M 199M 203M 182M 189M 196M 178M 158M 147M 135M
shortTermDebt 24M 56M 33M 33M 26M 21M 121M 121M 121M 120M 19M 17M 112M 2M
taxPayables 0 0 143M 0 0 0 157M 0 0 0 104M 0 91M 117M
deferredRevenue 0 478M 438M 467M 502M 485M 400M 381M 397M 401M 370M 176M 336M 307M
otherCurrentLiabilities 1 059M 571M 300M 595M 556M 477M 218M 389M 344M 334M 160M 514M 156M 121M
totalCurrentLiabilities 1 268M 1 347M 1 281M 1 322M 1 305M 1 183M 1 202M 1 072M 1 051M 1 052M 914M 865M 939M 792M
longTermDebt 2 025M 2 380M 2 062M 2 265M 2 243M 1 357M 1 160M 1 099M 1 123M 1 109M 1 201M 1 137M 1 222M 842M
deferredRevenueNonCurrent 0 0 100M 0 94M 106M 92M 0 0 0 102M 0 50M 51M
deferredTaxLiabilitiesNonCurrent 0 0 119M 0 179M 82M 68M 0 0 0 62M 0 46M 43M
otherNonCurrentLiabilities 649M 746M 311M 701M 258M 328M 240M 403M 421M 392M 167M 1 168M 267M 300M
totalNonCurrentLiabilities 2 674M 3 126M 2 710M 2 966M 2 774M 1 873M 1 635M 1 502M 1 544M 1 501M 1 566M 1 519M 1 627M 1 283M
otherLiabilities 0 0 0 -18M 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 19M 0 151M 0 111M 86M 98M 20M 0 0 51M 0 60M 68M
totalLiabilities 3 943M 4 473M 3 992M 4 270M 4 078M 3 056M 2 837M 2 574M 2 594M 2 553M 2 480M 2 383M 2 565M 2 075M
preferredStock 0 0 0 0 0 16M 0 0 0 0 0 0 0 0
commonStock 2M 2M 2M 0 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
retainedEarnings 2 352M 2 416M 2 407M 0 2 367M 2 367M 2 324M 0 0 0 1 926M 0 1 660M 1 407M
accumulatedOtherComprehensiveIncomeLoss -79M -97M -104M -62M -44M -8M 6M -5M 24M 30M 15M -92M -8M 4M
othertotalStockholdersEquity 157M -517M 1 887M -536M -962M 1 231M 1 225M 1 168M 1 038M
totalStockholdersEquity 2 432M 1 804M 1 781M 1 825M 1 789M 1 415M 1 377M 1 227M 1 251M 1 199M 1 114M 948M 1 071M 961M
totalEquity 2 492M 1 867M 1 815M 1 843M 1 825M 1 451M 1 413M 1 244M 1 263M 1 199M 1 132M 948M 1 085M 974M
totalLiabilitiesAndStockholdersEquity 6 435M 6 340M 6 113M 5 903M 4 506M 3 818M 3 857M 3 764M 3 337M
minorityInterest 61M 63M 34M 18M 35M 36M 36M 17M 12M 12M 18M 0 14M 13M
totalLiabilitiesAndTotalEquity 6 435M 6 340M 5 807M 6 113M 5 903M 4 506M 4 250M 3 818M 3 857M 3 764M 3 612M 3 337M 3 650M 3 049M
totalInvestments 8M 0 0 0 11M 22M 0 19M 0 0 0 0 100M 50M
totalDebt 2 049M 2 435M 2 245M 2 297M 2 270M 1 464M 1 380M 1 220M 1 243M 1 229M 1 270M 1 154M 1 394M 913M
netDebt 1 754M 2 343M 2 062M 2 149M 2 100M 1 124M 891M 856M 669M 631M 625M 528M 326M 231M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-03 2024-02-29 2022-12-31 2022-02-28 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 566M 492M 473M 417M 335M
otherReceivables 136M 130M 123M 0 0
prepaids 61M 56M 43M 0 0
totalPayables 377M 360M 282M 238M 251M
otherPayables 143M 157M 104M 91M 117M
accruedExpenses 102M 79M 67M 78M 89M
capitalLeaseObligationsCurrent 32M 23M 16M 18M 21M
capitalLeaseObligationsNonCurrent 119M 75M 35M 42M 47M
treasuryStock -1 237M -1 237M -1 085M -820M -667M
additionalPaidInCapital 713M 283M 256M 238M 216M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR BRKR
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-05 2025-08-06 2024-11-05 2024-08-09 2024-05-10 2023-11-09 2023-08-09 2023-05-10 2022-11-04
acceptedDate 2025-11-05 16:30:06 2025-08-05 19:05:54 2025-03-03 16:27:32 2024-11-05 07:00:10 2024-08-09 16:41:48 2024-05-10 15:29:53 2024-02-29 15:58:08 2023-11-09 16:54:36 2023-08-09 15:27:25 2023-05-10 15:10:36 2022-12-31 00:00:00 2022-11-04 15:11:06 2022-02-28 10:46:59 2021-03-01 15:37:40
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome -59M 4M 114M 41M 8M 51M 427M 89M 58M 77M 299M 88M 281M 161M
depreciationAndAmortization 56M 56M 184M 51M 45M 35M 115M 27M 26M 25M 89M 21M 89M 81M
deferredIncomeTax -27M -16M -64M -22M -20M -2M -24M 3M 8M 1M -15M -18M -6M -23M
stockBasedCompensation 0 0 25M 6M 7M 5M 24M 6M 6M 5M 28M 5M 17M 16M
changeInWorkingCapital -118M -160M -78M -47M -58M -63M -88M -85M -100M -24M -144M -36M -125M 70M
accountsReceivables 0 0 -41M -19M 14M 16M -900 000 -43M 22M 8M -68M -35M -95M 41M
inventory 0 0 -70M -11M -29M -65M -125M -34M -59M -55M -138M -35M -67M -92M
accountsPayables 0 0 21M 21M 9M -4M 23M 14M -17M 14M 33M 18M 62M -2M
otherWorkingCapital -118M -160M 11M -38M -52M -11M 15M -23M -47M 9M 28M 17M -25M 123M
otherNonCashItems 114M -12M 70M 9M 123M 124M -104M 5M 16M 2M 18M 8M 27M 27M
netCashProvidedByOperatingActivities -33M -128M 251M 38M 1M 22M 350M 44M 13M 88M 274M 70M 282M 332M
investmentsInPropertyPlantAndEquipment -21M -21M -115M -33M -25M -21M -107M -27M -24M -25M -129M -58M -92M -97M
acquisitionsNet -200 000 -68M -1 600M -200 000 -1 302M -275M -227M -120M -3M -88M -182M -100 000 -65M -59M
purchasesOfInvestments 0 0 -48M 0 0 -10M -25M -10M -1M -8M -60M -3M -149M -151M
salesMaturitiesOfInvestments 0 0 5M -3M 1M 1M 21M 1M 1M 2M 106M 3M 108M 115M
otherInvestingActivites -3M -1M -32M 1M 1M 200 000 0 11M 0
netCashUsedForInvestingActivites -24M -91M -68M -1 325M -305M -155M -26M -108M -58M
debtRepayment -416M 103M 14M 759M -157M -6M -6M -6M -1M
commonStockIssued -1M -400 000 800 000 404M 3M 2M 2M 700 000 -3M
commonStockRepurchased 0 0 0 0 0 0 -152M -80M 3M -22M -263M -73M -153M -123M
dividendsPaid 0 -8M -8M -8M -7M -7M -7M -7M -7M
otherFinancingActivites 676M 1 000 000 -10M 1 000 000 -900 000 -1M -2M 4M 2M
netCashUsedProvidedByFinancingActivities 258M 96M -3M 1 156M 153M -93M -10M -31M -82M
effectOfForexChangesOnCash -300 000 32M -29M 10M -2M -18M 12M -8M 100 000 4M -31M -27M -23M 26M
netChangeInCash 201M -92M -305M -18M -170M -148M -157M -211M -23M -47M -423M -97M 386M 4M
cashAtEndOfPeriod 297M 96M 187M 152M 170M 340M 492M 367M 578M 601M 649M 629M 1 072M 686M
cashAtBeginningOfPeriod 96M 188M 492M 170M 340M 488M 649M 578M 601M 649M 1 072M 726M 686M 682M
operatingCashFlow -33M -128M 251M 38M 1M 22M 350M 44M 13M 88M 274M 70M 282M 332M
capitalExpenditure -21M -21M -115M -33M -25M -21M -107M -27M -24M -25M -129M -58M -92M -97M
freeCashFlow -54M -149M 136M 6M -24M 400 000 243M 17M -11M 63M 145M 12M 190M 235M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-03 2024-02-29 2022-12-31 2022-02-28 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 1M 11M 14M 5M 200 000
netCashProvidedByInvestingActivities -1 757M -326M -252M -192M -193M
netDebtIssuance 876M -22M -111M 490M -8M
longTermNetDebtIssuance 876M -22M -111M 490M -8M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 403M -143M -263M -146M -120M
netCommonStockIssuance 403M -143M -263M -146M -120M
commonStockIssuance 403M 10M 0 7M 3M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid -30M -29M -30M -24M -25M
commonDividendsPaid -30M -29M -30M -24M -25M
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -19M 300 000 -12M -500 000 -9M
netCashProvidedByFinancingActivities 1 230M -193M -415M 319M -162M
incomeTaxesPaid 154M 97M 147M 146M 43M
interestPaid 55M 34M 24M 20M 29M

Earning call transcript

2025 q3
2025-11-03 ET (fiscal 2025 q3)
2025 q2
2025-08-04 ET (fiscal 2025 q2)
2025 q1
2025-05-07 ET (fiscal 2025 q1)
2024 q4
2025-02-13 ET (fiscal 2024 q4)
2024 q3
2024-11-05 ET (fiscal 2024 q3)
2024 q2
2024-08-09 ET (fiscal 2024 q2)
2024 q1
2024-05-02 ET (fiscal 2024 q1)
2023 q4
2024-02-13 ET (fiscal 2023 q4)
2023 q3
2023-11-03 ET (fiscal 2023 q3)
2023 q2
2023-08-03 ET (fiscal 2023 q2)
2023 q1
2023-05-06 ET (fiscal 2023 q1)
2022 q4
2023-02-09 ET (fiscal 2022 q4)
2022 q3
2022-11-05 ET (fiscal 2022 q3)
2022 q2
2022-08-03 ET (fiscal 2022 q2)
2022 q1
2022-05-04 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2025-11-03 07:00 ET
Bruker reported for 2025 q3
SEC form 8
2025-11-03 07:00 ET
Bruker published news for 2025 q3
SEC form 8
2025-08-04 11:00 ET
Bruker reported for 2025 q2
SEC form 8
2025-08-04 11:00 ET
Bruker published news for 2025 q2
SEC form 8
2025-07-21 00:00 ET
Bruker published news for 2025 q2
SEC form 8
2025-07-21 00:00 ET
Bruker published news for 2025 q2
SEC form 10
2025-05-07 20:04 ET
Bruker reported for 2025 q1
SEC form 8
2025-05-07 11:00 ET
Bruker published news for 2025 q1
SEC form 8
2025-05-07 11:00 ET
Bruker published news for 2025 q1
SEC form 10
2025-05-07 00:00 ET
Bruker published news for 2025 q1
SEC form 8
2025-04-11 00:00 ET
Bruker published news for 2025 q1
SEC form 8
2025-04-11 00:00 ET
Bruker published news for 2025 q1
SEC form 10
2025-03-03 00:00 ET
Bruker published news for 2024 q4
SEC form 8
2025-02-13 00:00 ET
Bruker reported for 2024 q4
SEC form 8
2025-02-13 00:00 ET
Bruker published news for 2024 q4
SEC form 8
2025-01-13 00:00 ET
Bruker published news for 2024 q4
SEC form 10
2024-11-07 16:06 ET
Bruker published news for 2024 q3
SEC form 8
2024-11-05 07:00 ET
Bruker published news for 2024 q3
SEC form 8
2024-11-05 07:00 ET
Bruker published news for 2024 q3
SEC form 10
2024-08-09 00:00 ET
Bruker published news for 2024 q2
SEC form 8
2024-08-06 07:00 ET
Bruker reported for 2024 q2
SEC form 8
2024-08-06 07:00 ET
Bruker published news for 2024 q2
SEC form 10
2024-05-10 00:00 ET
Bruker published news for 2024 q1
SEC form 8
2024-05-02 07:00 ET
Bruker reported for 2024 q1
SEC form 8
2024-05-02 07:00 ET
Bruker published news for 2024 q1
SEC form 10
2024-02-29 00:00 ET
Bruker published news for 2023 q4
SEC form 8
2024-02-13 00:00 ET
Bruker published news for 2023 q4
SEC form 8
2024-02-13 00:00 ET
Bruker reported for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Bruker published news for 2023 q4
SEC form 10
2023-11-09 00:00 ET
Bruker published news for 2023 q3
SEC form 8
2023-11-02 07:00 ET
Bruker reported for 2023 q3
SEC form 10
2023-08-09 00:00 ET
Bruker published news for 2023 q2
SEC form 6
2023-08-03 07:01 ET
Bruker reported for 2023 q2
SEC form 8
2023-08-03 00:00 ET
Bruker published news for 2023 q2
SEC form 6
2023-06-07 17:16 ET
Bruker published news for 2023 q1
SEC form 10
2023-05-10 00:00 ET
Bruker published news for 2023 q1
SEC form 8
2023-05-04 00:00 ET
Bruker published news for 2023 q1
SEC form 10
2023-03-01 00:00 ET
Bruker reported for 2022 q4
SEC form 8
2023-02-09 00:00 ET
Bruker reported for 2022 q4
SEC form 8
2023-01-09 00:00 ET
Bruker published news for 2022 q4
SEC form 10
2022-11-04 00:00 ET
Bruker reported for 2022 q3
SEC form 8
2022-11-03 00:00 ET
Bruker reported for 2022 q3
SEC form 10
2022-08-05 00:00 ET
Bruker reported for 2022 q2
SEC form 8
2022-08-03 00:00 ET
Bruker reported for 2022 q2
SEC form 10
2022-05-06 00:00 ET
Bruker reported for 2022 q1
SEC form 8
2022-05-04 00:00 ET
Bruker reported for 2022 q1
SEC form 10
2022-02-28 00:00 ET
Bruker published news for 2021 q4
SEC form 8
2022-02-11 00:00 ET
Bruker published news for 2021 q4
SEC form 8
2022-01-10 00:00 ET
Bruker published news for 2021 q4
SEC form 10
2021-11-05 00:00 ET
Bruker published news for 2021 q3
SEC form 8
2021-11-01 00:00 ET
Bruker published news for 2021 q3
SEC form 10
2021-08-05 00:00 ET
Bruker published news for 2021 q2
SEC form 8
2021-08-02 00:00 ET
Bruker published news for 2021 q2
SEC form 10
2021-05-10 00:00 ET
Bruker published news for 2021 q1
SEC form 8
2021-05-05 00:00 ET
Bruker published news for 2021 q1
SEC form 8
2021-04-13 00:00 ET
Bruker published news for 2021 q1